Cytoplasmic poly(A) binding protein-1 binds to genomically encoded sequences within mammalian mRNAs

por Kini, Hemant K., Silverman, Ian M., Ji, Xinjun, Gregory, Brian D., Liebhaber, Stephen A.
Publicado 2016

Evaluating the Impact of Sequencing Depth on Transcriptome Profiling in Human Adipose

por Liu, Yichuan, Ferguson, Jane F., Xue, Chenyi, Silverman, Ian M., Gregory, Brian, Reilly, Muredach P., Li, Mingyao
Publicado 2013

RNase-mediated protein footprint sequencing reveals protein-binding sites throughout the human transcriptome

por Silverman, Ian M, Li, Fan, Alexander, Anissa, Goff, Loyal, Trapnell, Cole, Rinn, John L, Gregory, Brian D
Publicado 2014

A comprehensive database of high-throughput sequencing-based RNA secondary structure probing data (Structure Surfer)

por Berkowitz, Nathan D., Silverman, Ian M., Childress, Daniel M., Kazan, Hilal, Wang, Li-San, Gregory, Brian D.
Publicado 2016

Terpene metabolic engineering via nuclear or chloroplast genomes profoundly and globally impacts off‐target pathways through metabolite signalling

por Pasoreck, Elise K., Su, Jin, Silverman, Ian M., Gosai, Sager J., Gregory, Brian D., Yuan, Joshua S., Daniell, Henry
Publicado 2016

HAMR: high-throughput annotation of modified ribonucleotides

por Ryvkin, Paul, Leung, Yuk Yee, Silverman, Ian M., Childress, Micah, Valladares, Otto, Dragomir, Isabelle, Gregory, Brian D., Wang, Li-San
Publicado 2013

Dynamic changes in RNA–protein interactions and RNA secondary structure in mammalian erythropoiesis

por Shan, Mengge, Ji, Xinjun, Janssen, Kevin, Silverman, Ian M, Humenik, Jesse, Garcia, Ben A, Liebhaber, Stephen A, Gregory, Brian D
Publicado 2021

Impact of poly(A)-tail G-content on Arabidopsis PAB binding and their role in enhancing translational efficiency

por Zhao, Taolan, Huan, Qing, Sun, Jing, Liu, Chunyan, Hou, Xiuli, Yu, Xiang, Silverman, Ian M., Zhang, Yi, Gregory, Brian D., Liu, Chun-Ming, Qian, Wenfeng, Cao, Xiaofeng
Publicado 2019

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

por Yap, Timothy A., Fontana, Elisa, Lee, Elizabeth K., Spigel, David R., Højgaard, Martin, Lheureux, Stephanie, Mettu, Niharika B., Carneiro, Benedito A., Carter, Louise, Plummer, Ruth, Cote, Gregory M., Meric-Bernstam, Funda, O’Connell, Joseph, Schonhoft, Joseph D., Wainszelbaum, Marisa, Fretland, Adrian J., Manley, Peter, Xu, Yi, Ulanet, Danielle, Rimkunas, Victoria, Zinda, Mike, Koehler, Maria, Silverman, Ian M., Reis-Filho, Jorge S., Rosen, Ezra
Publicado 2023

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas

por Juratli, Tareq A., Thiede, Christian, Koerner, Mara V.A., Tummala, Shilpa S., Daubner, Dirk, Shankar, Ganesh M., Williams, Erik A., Martinez-Lage, Maria, Soucek, Silke, Robel, Katja, Penson, Tristan, Krause, Mechthild, Appold, Steffen, Meinhardt, Matthias, Pinzer, Thomas, Miller, Julie J., Krex, Dietmar, Ely, Heather A., Silverman, Ian M., Christiansen, Jason, Schackert, Gabriele, Wakimoto, Hiroaki, Kirsch, Matthias, Brastianos, Priscilla K., Cahill, Daniel P.
Publicado 2017

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

por Zingg, Daniel, Bhin, Jinhyuk, Yemelyanenko, Julia, Kas, Sjors M., Rolfs, Frank, Lutz, Catrin, Lee, Jessica K., Klarenbeek, Sjoerd, Silverman, Ian M., Annunziato, Stefano, Chan, Chang S., Piersma, Sander R., Eijkman, Timo, Badoux, Madelon, Gogola, Ewa, Siteur, Bjørn, Sprengers, Justin, de Klein, Bim, de Goeij-de Haas, Richard R., Riedlinger, Gregory M., Ke, Hua, Madison, Russell, Drenth, Anne Paulien, van der Burg, Eline, Schut, Eva, Henneman, Linda, van Miltenburg, Martine H., Proost, Natalie, Zhen, Huiling, Wientjens, Ellen, de Bruijn, Roebi, de Ruiter, Julian R., Boon, Ute, de Korte-Grimmerink, Renske, van Gerwen, Bastiaan, Féliz, Luis, Abou-Alfa, Ghassan K., Ross, Jeffrey S., van de Ven, Marieke, Rottenberg, Sven, Cuppen, Edwin, Chessex, Anne Vaslin, Ali, Siraj M., Burn, Timothy C., Jimenez, Connie R., Ganesan, Shridar, Wessels, Lodewyk F. A., Jonkers, Jos
Publicado 2022

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

por Zingg, Daniel, Bhin, Jinhyuk, Yemelyanenko, Julia, Kas, Sjors M., Rolfs, Frank, Lutz, Catrin, Lee, Jessica K., Klarenbeek, Sjoerd, Silverman, Ian M., Annunziato, Stefano, Chan, Chang S., Piersma, Sander R., Eijkman, Timo, Badoux, Madelon, Gogola, Ewa, Siteur, Bjørn, Sprengers, Justin, de Klein, Bim, de Goeij-de Haas, Richard R., Riedlinger, Gregory M., Ke, Hua, Madison, Russell, Drenth, Anne Paulien, van der Burg, Eline, Schut, Eva, Henneman, Linda, van Miltenburg, Martine H., Proost, Natalie, Zhen, Huiling, Wientjens, Ellen, de Bruijn, Roebi, de Ruiter, Julian R., Boon, Ute, de Korte-Grimmerink, Renske, van Gerwen, Bastiaan, Féliz, Luis, Abou-Alfa, Ghassan K., Ross, Jeffrey S., van de Ven, Marieke, Rottenberg, Sven, Cuppen, Edwin, Chessex, Anne Vaslin, Ali, Siraj M., Burn, Timothy C., Jimenez, Connie R., Ganesan, Shridar, Wessels, Lodewyk F. A., Jonkers, Jos
Publicado 2022